BioSpace News Archive

Genetown

Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company

Sage Therapeutics today announced that in a corporate presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco.

January 8, 2018
·
9 min read
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures

Acasti announces that in accordance with the terms of its outstanding convertible debentures in the total aggregate principal amount of $2,000,000 issued on February 21, 2017.

January 8, 2018
·
3 min read
Deals

The Medicines Company Announces Closing of Divestiture of Infectious Disease Business Unit to Melinta Therapeutics

The Company expects to provide additional details regarding its cash position and plans as part of its fourth quarter and full year 2017 financial results.

January 8, 2018
·
4 min read
Pharm Country

Mylan to Complete $1B Share Repurchase Plan

Mylan today announced that it is completing its previously-approved $1B share repurchase plan.

January 8, 2018
·
4 min read
BioCapital

CEL-SCI Awarded Patent for LEAPS Vaccine in Treatment of Rheumatoid Arthritis

CEL-SCI Corporation today announced that the European Patent Office has issued CEL-SCI patent EP 2254588B1 titled, “Method of Preparation and Composition of Peptide Constructs for Treatment of Rheumatoid Arthritis” for the Company’s LEAPS™(*) platform technology.

January 8, 2018
·
5 min read
Deals

Baxter Announces Agreement to Broaden Portfolio of Innovative Surgical Products

Baxter announced an agreement to acquire two hemostat and sealant products from Mallinckrodt plc: RECOTHROM Thrombin topical (Recombinant), the first and only stand-alone recombinant thrombin, and PREVELEAK Surgical Sealant, which is used in vascular reconstruction.

January 8, 2018
·
9 min read
Business

Common Sensing Announces Kevin Schmid as Chief Operating Officer

Mr. Schmid brings extensive business development and operations leadership experience, having previously served in pivotal roles at Insulet Corporation, Bose Corporation, JDS Uniphase, and the Stevanato Group.

January 8, 2018
·
2 min read
Business

10x Genomics Announces Collaboration with Berry Genomics to Develop Next Generation Noninvasive Prenatal Testing (NIPT)

The parties will collaborate to enable a new service offering for Berry Genomics.

January 8, 2018
·
3 min read
Business

AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2018 Earnings Release

AmerisourceBergen announced that it plans to release its results for the First Quarter Fiscal 2018 on Tuesday, February 6, 2018 prior to the opening of trading on the New York Stock Exchange.

January 8, 2018
·
7 min read
Business

MGI Genetic Sequencer Certified in New 10x Genomics Compatible Program

10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program.

January 8, 2018
·
3 min read